Strength
300 mg/1
Manufacturer
Endo USA Inc.NDC
49884042511
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
ALISKIREN HEMIFUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA206665On Market Since
3/25/2019
Pharmacological Classes
Renin Inhibitor
Renin Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.